Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colleoni

Showing results (101-110 of 264) with videos related to

Pageof 27
Sort By:
Clinical Breast Cancer|November 5, 2013
Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastasesSilvia Dellapasqua, Vincenzo Bagnardi, Alessandra Balduzzi, et al.
Cancer Letters|January 30, 2017
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trialEmilia Montagna, Antonella Palazzo, Patrick Maisonneuve, et al.
Clinical Breast Cancer|December 19, 2012
Immunohistochemically defined subtypes and outcome of apocrine breast cancerSilvia Dellapasqua, Patrick Maisonneuve, Giuseppe Viale, et al.
Breast Cancer Research and Treatment|October 8, 2008
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivityGiuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, et al.
Breast Cancer Research and Treatment|July 11, 2014
Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancerElisabetta Munzone, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Breast Cancer Research : BCR|March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studiesJohannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancerGiuseppe Curigliano, Giuseppe Viale, Vincenzo Bagnardi, et al.
Breast (Edinburgh, Scotland)|July 4, 2008
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptorsRosalba Torrisi, Silvia Dellapasqua, Raffaella Ghisini, et al.
Anti-Cancer Drugs|November 1, 2006
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancerAndrea Rocca, Giulia Peruzzotti, Raffaella Ghisini, et al.
Breast Cancer Research and Treatment|March 13, 2009
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapyEugenio Maiorano, Meredith M Regan, Giuseppe Viale, et al.
Pageof 27

Showing results (101-110 of 264) with videos related to

Sort By:
Pageof 27
Clinical Breast Cancer|November 5, 2013
Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastasesSilvia Dellapasqua, Vincenzo Bagnardi, Alessandra Balduzzi, et al.
Cancer Letters|January 30, 2017
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trialEmilia Montagna, Antonella Palazzo, Patrick Maisonneuve, et al.
Clinical Breast Cancer|December 19, 2012
Immunohistochemically defined subtypes and outcome of apocrine breast cancerSilvia Dellapasqua, Patrick Maisonneuve, Giuseppe Viale, et al.
Breast Cancer Research and Treatment|October 8, 2008
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivityGiuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, et al.
Breast Cancer Research and Treatment|July 11, 2014
Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancerElisabetta Munzone, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Breast Cancer Research : BCR|March 14, 2020
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studiesJohannes Ettl, Seock-Ah Im, Jungsil Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancerGiuseppe Curigliano, Giuseppe Viale, Vincenzo Bagnardi, et al.
Breast (Edinburgh, Scotland)|July 4, 2008
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptorsRosalba Torrisi, Silvia Dellapasqua, Raffaella Ghisini, et al.
Anti-Cancer Drugs|November 1, 2006
A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancerAndrea Rocca, Giulia Peruzzotti, Raffaella Ghisini, et al.
Breast Cancer Research and Treatment|March 13, 2009
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapyEugenio Maiorano, Meredith M Regan, Giuseppe Viale, et al.
Pageof 27